Bristol-Myers Squibb divested the Questran range to Cheplapharm at the end of July 2019. This affected the availability of several bile acid sequestrants. The current stock situation is as follows:
- Questran Light (Cheplapharm) – available in limited quantities
- Questran (Cheplapharm) – out of stock; not expected before 2021
- Colestyramine light 4g sachets (Mylan)– in stock
- Cholestagel (colesevelam) 625mg tablets (Sanofi) – in stock
- Colestid (colestipol) plain (Pfizer) – out of stock; until early November 2020
- Colestid (colestipol) Orange (Pfizer) – out of stock; until end of February 2021
This memo advises on management options until the shortage resolves.